MedPath

Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded to non-surgical treatment favorably.

Not Applicable
Conditions
unresectable pancreatic cancer
Registration Number
JPRN-UMIN000031131
Lead Sponsor
Hokkaido University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
34
Inclusion Criteria

Not provided

Exclusion Criteria

Patients judged inappropriate as research subjects by research managers

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath